Austria Signals Endocrine Disruptor Proposal for Potassium Chlorate Under EU CLP

Potassium chlorate already has a harmonised classification in EU CLP Annex VI, and Austria’s intention indicates that additional hazard endpoints may be assessed for a future update. For manufacturers, importers, and downstream users, the value of the intention stage is early visibility: it provides a long lead time to screen portfolios and prepare for possible classification and labelling changes if the proposal progresses through the EU process.

What The Intention Covers

ECHA’s registry entry lists potassium chlorate’s existing harmonised classification at the time of the intention as Ox. Sol. 1 (H271) and Acute Tox. 3 (H301), with an oral ATE of 100 mg/kg body weight. Austria’s proposed harmonised classification by the dossier submitter includes those same hazard classes and adds endocrine disruptor hazard classes for:

• Human health
• The environment

At this stage, consultation dates and commenting deadlines are not yet published in the registry entry.

Why It Matters For Supply Chains

If the proposal develops into a submitted dossier and ultimately results in an updated Annex VI entry, businesses placing substances and mixtures on the market may need to reassess classification decisions, update labels and safety data sheets, and review how mixtures containing potassium chlorate are classified. Beyond regulatory documentation, changes can cascade into procurement controls, customer specifications, and internal risk assessments, especially where potassium chlorate is used as a strong oxidiser.

For organisations operating across the European Economic Area, including supply chains affecting Northern Ireland, early monitoring can reduce disruption. Practical steps include confirming where potassium chlorate is used, validating the current hazard communication package, and maintaining a watchlist for ECHA milestones such as dossier submission, consultation launch, and the Committee for Risk Assessment (RAC) timeline.

Summary

Austria’s notification to ECHA signals a planned CLH dossier for potassium chlorate, with a proposed addition of endocrine disruptor hazard classes alongside its existing Annex VI classification. While an intention is not a final outcome, it is a useful early warning for companies to scope potential impacts and prepare for future EU CLP compliance updates.